Post-doc Tal Danino's work with artist Vik Muniz is highlighted in a new online campaign promoting vaccination, sponsored by the Bill & Melinda Gates Foundation. More information about the campaign can be found through its website, and full coverage is featured in the New York Times.

A decorative image of liver cells infected with Vaccinia virus, designed by Tal and Vik Muniz.

Dr. Bhatia is featured in Entrepreneur Magazine, among the "Women to Watch" in their January 2015 issue.

Congratulations to post-doctoral fellow Tal Danino on being selected as one of 21 TED Fellows for 2015. Each year, the program selects 20 unconventional change-makers to join the TED fellows program, a global network of innovators from a wide spectrum of disciplines.

See more at the TED Blog:

Fox News coverage features Dr. Bhatia's participation in the Milken Institute’s “Partnering for Cures” conference, where she discussed the importance of combining medicine with technology to achieve breakthroughs in health.

Dr. Bhatia has been awarded one of five Prof. Amar G. Bose Research Grants. The grant, designed to fund "unfundable research" and will support the lab's efforts to develop technologies at the interface of synthetic biology and nanotechnology. Check out the full story by MIT News.

Foreign Policy magazine has selected Dr. Bhatia as one of their 2014 Leading Global Thinkers, highlighting the lab's work to develop non-invasive cancer diagnostics. She was selected as one of 100 that have contributed translational ideas in politics, business, technology, the arts, and the sciences with the potential to impact millions around the world.
See more information also through MIT News.

The lab's work on imaging tumors using carbon nanotubes is featured in Chemical Research in Toxicology's November Spotlight. See Ghosh, et al. PNAS 2014.

Dr. Bhatia has been featured in a profile in the magazine of the Society of Women Engineers (SWE) in their 2014 Conference issue. Check out the article here) and the full issue of the magazine through the SWE website.

Congratulations to graduate student Andrew Warren on winning the CHEMINAS Young Researcher Poster Award at the 2014 International Conference on Miniaturized Systems for Chemistry and Life Sciences (a.k.a. MicroTAS)! He won for his poster presentation of SiMoA detection of urinary synthetic biomarkers (see Warren et al., JACS 2014).

Congratulations to graduate students Justin Lo and Andrew Warren on winning Design and Research Awards at the 2014 BMES Annual Meeting!

Dr. Bhatia has been selected as the recipient of the 2014 Corning Inc./Lab on a Chip Pioneers of Miniaturisation Lectureship!

In September, the Koch Institute's "Bridging the Gap in Ovarian Cancer" symposium brought researchers, clinicians, patients, family members, and advocates together to explore translational ovarian cancer research from multiple perspectives. Dr. Bhatia discussed the lab's work using nanoparticles to deliver siRNA to ovarian tumors. Watch a video of her presentation here.

Gabriel Kwong, former postdoc and current assistant professor at the Georgia Institute of Technology and Emory University School of Medicine, discussed his work at LMRT developing ultra-sensitive, non-invasive diagnostics for early cancer detection. You can see his presentation here.

Find more information about the symposium through the American Association for Cancer Research.

The Fall 2014 edition of MIT's SPECTRVM Magazine features a profile of Dr. Bhatia. "Sophisticated Medicine."

Our recent work on single-molecule array (SiMoA) detection of synthetic biomarkers is featured in an article in Chemical & Engineering News: "Researchers Use Synthetic Biomarkers To Catch A Clot." Read more about the microdosed detection SiMoA technology in Warren, et al., JACS 2014.

The lab's cancer-diagnostic probiotic technology is featured in the MIT Technology Review.

Dr. Bhatia's accomplishments as a researcher, inventor, and mentor were featured in a Boston Globe Editorial.

Read Dr. Bhatia's article in the MIT Technology Review: "Closing the High-Tech Gender Gap." In it, she discusses grassroots ways for boosting the number of women in technology and business.

Sangeeta Bhatia has been selected as the recipient of the 2014 Lemelson-MIT Prize. The Lemelson-MIT Prize, celebrating its 20th year, honors outstanding mid-career inventors improving the world through technological invention and demonstrating a commitment to mentorship in science, technology, engineering and mathematics. See more about the award and her biography on the Lemelson-MIT Prize page.

Photo courtesy of the Lemelson-MIT Program.

Featured in a variety of news outlets, including:

  • NBC News
  • Boston Globe
  • MIT News
  • BostInno
  • HHMI News
  • ECN Magazine
  • Big Think
  • Inside Philanthropy

  • Tal Danino's collaborative art project (see below) "Colonies" is featured on CNET. His work alongside artist Vik Muniz has been exhibited in New York, Tel Aviv, and Sao Paulo, with proceeds from the shows going toward cancer research.

    Feature in The Scientist highlights growing clinical potential for RNAi and its use in the Bhatia lab.

    The lab's anticoagulant NanoSTAT technology is featured in Chemical & Engineering News. Check out the paper here, too.

    Post-doctoral researcher Tal Danino featured at the Galeria Nara Roesler in São Paulo, Brazil, for his work alongside artist Vik Muniz. A conversation between Vik, Tal, and the Galeria is described in this Koch Institute News Feature. Another article on The Creators Project describes the artistic collaboration.
    Check out a video about the project, too!

    You can find more information on Tal's website.

    Model of viral lifecycle could help in finding a cure for hepatitis B: research from the lab featured by the MIT News Office

    Image courtesy of the Centers for Disease Control and Prevention

    State of the Art Review from Bhatia and colleagues featured on the cover of Science Translational Medicine: 'Cell and tissue engineering for liver disease'

    Progress towards building artificial livers featured on NPR's 'Here and Now'

    Bhatia named among the 100 Most Creative People in Business by Fast Company

    Boston Globe features LMRT's low cost urine test for cancer in their Magazine.

    Bhatia lab trainee, Alex Bagley, highlighted at Koch Institute image awards

    Latest advance in our synthetic biomarker platform achives cancer detection by paper test

    Featured on the MIT home page and covered widely in:

    Collaboration with Manalis lab (Olcum et al, PNAS) highlights attogram scale measurements

    Sangeeta Bhatia recruited to join the Ludwig Center for Molecular Oncology

    TomoNews US animates recent publication on nanoparticle detection of thrombosis (Lin et al.)

    Technology Review features Lin et al Thrombosis diagnostic

    Sangeeta Bhatia named one of three Merkin Fellows by the Broad Institute of MIT and Harvard

    March et. al. MPCC platform for human Malaria (CHM, 2013) makes Top 10 list in Malaria Nexus

    Sangeeta Bhatia selected as one of '10 most influential women in biotech'

    Our game NanoDoc to crowdsource nanomedicine attracts wide media attention

    Featured on:

    Synthetic Biomarker platform (NBT, 2012; ACS Nano, 2013; PNAS, 2014) awarded catalyst translation grant from the Deshpande Center for Technological Innovation

    March et. al. MPCC platform for human Malaria (CHM, 2013) featured in Malaria Nexus

    Synthetic biomarker platform (Kwong et al, NBT 2012) also detects blood clots
    Featured on MIT home page and covered widely in: Also featured on the ACS Nano journal homepage:

    Sangeeta Bhatia profiled at the Broad Institute via the 'Five Questions' interview format

    Hepregen launches new human MPCC-based products for drug screening

    Collaboration with the Broad Institute uncovers small molecules that expand and mature human liver cells

    Featured on the MIT home page and also by: Coverage includes commentary on Stevens et al, in Nature Communications

    Gates Foundation-funded work on In Vitro platform for Human Malaria research (March et al., 2013) widely touted
    Press coverage includes:

    Postdoc Sabine Hauert featured in Nature blog at the Lindau Nobel conference

    Profile of Sangeeta Bhatia in "The Scientist"
    When molecular biology methods failed her, Sangeeta Bhatia turned to engineering and microfabrication to build a liver from scratch.

    Science without borders: Becoming cross-disciplinary

    Grant to fund nanotech therapies for traumatic brain injuries
    MIT's Sangeeta Bhatia is part of the research team funded by the $6 million DARPA grant.

    InVERT molding paper featured on Nature Communications homepage

    "New technology may enable earlier cancer diagnosis": MIT News Office features the lab's synthetic biomarkers platform-- new technology that amplifies tumor signals, enabling earlier and more sensitive cancer diagnosis.

    Nanoparticles amplify tumor signals, as covered in:

    Bhatia lab contributions highlighted following launch of MIT's new 'Institute for Medical Engineering and Science'

    Science and Science Translational Medicine have collaborated to publish a special feature on 'Biomaterials'. The package includes a Commentary article that combines short essays from invited Thought Leaders in the field - including Sangeeta Bhatia.

    Check out our new videos that depict "Nanoparticle Transport in Tumors" with public-friendly language and graphics!

    Nature Materials, now 10 years old, selected our paper (Park et. al., 2009) as one of their 20 "Landmark Articles."

    How cancer cells break free from tumors, as covered in:

    Most emailed article on

    siRNA Nanoparticles Validate Cancer Targets, as covered in:

    MIT spotlight: Nanoparticles show potential to shrink tumors

    Chen/Bhatia lab collaboration: 3D-printed sugar network to help grown artificial liver
    See coverage in:

    Huffington Post UK highlights our 2012 Wellcome Image Award

    Our progress in liver tissue engineering featured in context with a new unpublished advance

    MIT’s 2012 IdeaStream Symposium allowed some of MIT’s brightest innovators to connect with a host of entrepreneurs and leaders in the business community. See GABE KWONG discuss what technological developments could be hitting the market someday on Greater Boston on WGBH.

    More coverage of HEALs
    ‘Humanized mice with ectopic artificial liver tissues’ (Chen et al., 2011) has been recently featured by Kamiya & Miyajima, (2012) Hepatology, Volume 55, Issue 3

    Wood et al. have created a microfluidic device that can measure decreased flow velocity in blood samples from patients with sickle cell disease.
    Also covered in:

    Sangeeta Bhatia gives 2 seminars on Engineering Tissue Replacements and and Microscale Liver Tissue Engineering, through iBioSeminars:

    NextGen Voices
    Congratulations to Vyas Ramanan and Andrew Warren who had their essays selected for online publication in Science NextGEN Voices:

    Stem cells could drive hepatitis research forward
    Scientists establish HCV infection in liver-like cells derived from iPSCs (pdf)
    Featured in:

    "A New Era in Cancer Research" A feature in THE MIT SPECTRVM highlights collaborative cancer research taking place in the Koch Institute.

    Changing the World
    Eighteen Indian Scientists Who Are Changing the World: Forbes India, 2012

    Particle physic
    Taking advantage of a natural signalling system enables nanoparticles to deliver cancer drugs far more accurately

    MIT Spotlight: Recreating human livers, in mice

    NOVA Profile: Sangeeta Bhatia
    Intrigued by the idea of artificial organs, a biomedical engineer uses computer-chip technology to craft tiny livers.

    Inside the Lab
    Learn more about the work the Bhatia lab is doing to use micro and nanotechnologies to improve the effectiveness of chemotherapy.

    Artificial liver tissue predicts drug safety
    Bhatia’s labo hs developed artificial human liver tissue that can be implanted in mice.

    Recreating human livers, in mice
    ‘Humanized’ mice could help scientists study the side effects of new drugs before they reach clinical trials.

    Mice with human livers deal with drugs the human way
    'Humanized' mice could provide better assessment of drugs' toxicity for humans.

    Nanoparticles communicate with each other inside the body to target tumors
    Researchers from the LMRT and other labs have designed a new type of delivery system that dispenses cancer drugs.

    Nanomedicine: Swarming towards the target
    A system comprising 'signalling' and 'receiving' modules improves the targeting effect of a nanomedicine.

    Nanoparticles hit tumours with one-two punch
    Using scout particles to pave the way makes drug delivery more effective.

    MIT Spotlight: Working in harmony
    MIT-designed nanoparticles communicate with each other inside the body to target tumors more efficiently.

    Koch Institute Research: Nanoparticles that Talk to One Other
    Former Bhatia lab graduate student Geoff von Maltzahn discusses a new system that allows nanoparticles to communicate for more efficient cancer targeting.

    Tissue models: A living system on a chip
    Devices that combine cells and nanotechnology to reconstruct tissues and organs are now edging from cool concept to practical application.

    Student inventor Alice Chen receives Lemelson-MIT Student Prize
    $30,000 prizes awarded to inventive students nationwide; four leading universities celebrate 2011 winners

    WBUR interview: Local Student Wins Prize For "Humanized" Mouse

    Engineering a new way to study hepatitis C
    Tissue engineers have successfully infected liver cells in the laboratory, allowing a better way to test new drugs.

    Lab-grown Liver Cells Provide Model for Hepatitis C Infection
    HHMI researchers and colleagues have developed a new method for growing human liver cells outside the body.

    Hepatitis fight aided by liver cells advance
    Scientists looking for a treatment for a dangerous liver virus have found new ways to study it in the laboratory.

    Researchers develop 'nano cocktail' to target and kill tumors
    Researchers at the LMRT have developed a "cocktail" of different nanometer-sized particles that locate, adhere to, and kill cancerous tumors.

    Three MIT students are Rhodes Scholars
    Steven Mo, 21, conducted more than 2,400 hours of research in Professor Sangeeta Bhatia’s laboratory, where he researched regenerative technologies.

    Lemelson-MIT Student Prize Winner Presentation - Geoffrey von Maltzahn

    Nature Materials News and Views
    Nanoantennas heat up

    Forbes 2009
    Living Livers

    Davos 2009 IdeasLab - Sangeeta Bhatia

    FOX News
    "Nanoworm" interview with Geoff von Maltzahn

    Boston Globe
    Her studies link engineering, biology

    Technology Review

    A Better Toxicity Test

    MIT nanoEECS
    Why small is beautiful in Electrical Engineering and Computer Science (pdf)

    The Scientist
    Sangeeta Bhatia Looks at Life's Architecture

    Nanotechnology Now
    Sangeeta Bhatia of MIT Pioneers Key Biomedical Advances

    Sangeeta Bhatia of MIT Pioneers Key Biomedical Advances

    MIT News
    Team develops nanoparticles to battle cancer

    MIT News
    'Micro' livers could aid drug screening

    MIT News
    Remote-control nanoparticles deliver drugs directly into tumors

    MIT News
    HST device draws cells close--but not too close--together

    MIT News
    MIT nanoparticles may help detect, treat tumors

    MIT News
    MIT method allows 3-D study of cell tissue organization